These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 11196170

  • 1. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.
    Cancer Res; 2001 Jan 01; 61(1):249-55. PubMed ID: 11196170
    [Abstract] [Full Text] [Related]

  • 2. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC, Lam SY, Tsang KW, Lam B, Ho JC, Fu KH, Lam WK, Kwong YL.
    Clin Cancer Res; 2002 Dec 01; 8(12):3741-6. PubMed ID: 12473584
    [Abstract] [Full Text] [Related]

  • 3. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT, Lee SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2005 Apr 01; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [Abstract] [Full Text] [Related]

  • 4. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP.
    Clin Cancer Res; 2002 Jan 01; 8(1):131-7. PubMed ID: 11801549
    [Abstract] [Full Text] [Related]

  • 5. Promoter methylation status of multiple genes in brain metastases of solid tumors.
    Gonzalez-Gomez P, Bello MJ, Alonso ME, Amiñoso C, Lopez-Marin I, De Campos JM, Isla A, Gutierrez M, Rey JA.
    Int J Mol Med; 2004 Jan 01; 13(1):93-8. PubMed ID: 14654977
    [Abstract] [Full Text] [Related]

  • 6. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, Sidransky D.
    Clin Cancer Res; 2003 Apr 01; 9(4):1370-5. PubMed ID: 12684406
    [Abstract] [Full Text] [Related]

  • 7. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.
    Carcinogenesis; 2008 Sep 01; 29(9):1845-9. PubMed ID: 18632757
    [Abstract] [Full Text] [Related]

  • 8. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.
    Cancer Res; 2002 Apr 15; 62(8):2370-7. PubMed ID: 11956099
    [Abstract] [Full Text] [Related]

  • 9. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.
    Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L.
    Cancer Res; 2002 Jan 15; 62(2):351-5. PubMed ID: 11809677
    [Abstract] [Full Text] [Related]

  • 10. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT.
    Cancer Res; 2001 Apr 15; 61(8):3419-24. PubMed ID: 11309302
    [Abstract] [Full Text] [Related]

  • 11. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
    Toyooka S, Maruyama R, Toyooka KO, McLerran D, Feng Z, Fukuyama Y, Virmani AK, Zochbauer-Muller S, Tsukuda K, Sugio K, Shimizu N, Shimizu K, Lee H, Chen CY, Fong KM, Gilcrease M, Roth JA, Minna JD, Gazdar AF.
    Int J Cancer; 2003 Jan 10; 103(2):153-60. PubMed ID: 12455028
    [Abstract] [Full Text] [Related]

  • 12. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
    Gilliland FD, Harms HJ, Crowell RE, Li YF, Willink R, Belinsky SA.
    Cancer Res; 2002 Apr 15; 62(8):2248-52. PubMed ID: 11956078
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.
    Schildhaus HU, Kröckel I, Lippert H, Malfertheiner P, Roessner A, Schneider-Stock R.
    Int J Oncol; 2005 Jun 15; 26(6):1493-500. PubMed ID: 15870861
    [Abstract] [Full Text] [Related]

  • 14. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.
    Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K, Kozuki T, Aoe M, Kiura K, Ueoka H, Tanimoto M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1219-25. PubMed ID: 15709192
    [Abstract] [Full Text] [Related]

  • 15. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J, Sidransky D.
    Cancer Res; 2001 Feb 01; 61(3):939-42. PubMed ID: 11221887
    [Abstract] [Full Text] [Related]

  • 16. Molecular genetics of small cell lung carcinoma.
    Wistuba II, Gazdar AF, Minna JD.
    Semin Oncol; 2001 Apr 01; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [Abstract] [Full Text] [Related]

  • 17. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY.
    Cancer; 2007 Dec 15; 110(12):2785-92. PubMed ID: 17960794
    [Abstract] [Full Text] [Related]

  • 18. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
    Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849
    [Abstract] [Full Text] [Related]

  • 19. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH.
    J Clin Oncol; 2004 Jun 15; 22(12):2363-70. PubMed ID: 15197197
    [Abstract] [Full Text] [Related]

  • 20. Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication.
    Shimamoto T, Ohyashiki JH, Hirano T, Kato H, Ohyashiki K.
    Oncol Rep; 2004 Aug 15; 12(2):389-95. PubMed ID: 15254707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.